VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
Chlamydia trachomatis
I. General Information
1. NCBI Taxonomy ID:
813
2. Disease:
Chlamydia
3. Introduction
Sexually transmitted Chlamydia trachomatis infection is a widespread public health concern because of its prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease (PID), infertility, and ectopic pregnancy. Although the pathologic consequences of infection are well established, the mechanism(s) of chlamydia-induced tissue damage are not fully understood (Darville and Hiltke, 2010).
4. Host Ranges and Animal Models
Chlamydia infects humans and there are established animal models in mice and guinea pigs (Darville and Hiltke, 2010).
5. Host Protective Immunity
Mouse and guinea pig models show that the response to primary chlamydial in fection occurs within 1–2 days of infection and is characterized by mucosal infiltration with neutrophils and modest numbers of monocytes. Neutrophils are recruited in large numbers to the site of infection and are capable of killing accessible elementary bodies. Later, T cells accumulate at the site of chlamydial infection and play a critical role in controlling the infection (Darville and Hiltke, 2010).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...